B. Metzler seel. Sohn & Co. Holding AG Buys New Shares in Avantor, Inc. (NYSE:AVTR)

B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of Avantor, Inc. (NYSE:AVTR) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 126,855 shares of the company’s stock, valued at approximately $3,282,000.

Several other large investors have also added to or reduced their stakes in the company. Versant Capital Management Inc lifted its holdings in shares of Avantor by 2,003.6% during the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock worth $25,000 after purchasing an additional 1,102 shares during the period. Blue Trust Inc. boosted its holdings in shares of Avantor by 1,830.3% in the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after acquiring an additional 1,391 shares during the last quarter. UMB Bank n.a. purchased a new position in shares of Avantor during the third quarter worth $49,000. Nisa Investment Advisors LLC lifted its position in Avantor by 69.6% during the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after purchasing an additional 835 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in Avantor by 89.9% in the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after purchasing an additional 1,285 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Insider Activity at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the transaction, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. The trade was a 10.66 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.30% of the stock is owned by corporate insiders.

Avantor Price Performance

Shares of NYSE AVTR opened at $20.14 on Thursday. The firm has a 50-day simple moving average of $24.14 and a 200-day simple moving average of $23.91. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The stock has a market capitalization of $13.71 billion, a price-to-earnings ratio of 43.78, a price-to-earnings-growth ratio of 2.52 and a beta of 1.35. Avantor, Inc. has a 52 week low of $19.49 and a 52 week high of $28.00.

Analyst Ratings Changes

AVTR has been the topic of a number of recent analyst reports. Morgan Stanley increased their price target on shares of Avantor from $28.00 to $29.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Barclays dropped their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Stifel Nicolaus upped their price target on Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Robert W. Baird dropped their price objective on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $34.00 target price on shares of Avantor in a research note on Thursday, September 26th. Three investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $27.57.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.